BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 3241241)

  • 1. Release of noradrenaline into the cerebrovascular circulation in patients with primary hypertension.
    Esler MD; Jennings GL; Lambert GW
    J Hypertens Suppl; 1988 Dec; 6(4):S494-6. PubMed ID: 3241241
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Jugular venous overflow of noradrenaline from the brain: a neurochemical indicator of cerebrovascular sympathetic nerve activity in humans.
    Mitchell DA; Lambert G; Secher NH; Raven PB; van Lieshout J; Esler MD
    J Physiol; 2009 Jun; 587(Pt 11):2589-97. PubMed ID: 19403604
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence for increased noradrenaline release from subcortical brain regions in essential hypertension.
    Ferrier C; Jennings GL; Eisenhofer G; Lambert G; Cox HS; Kalff V; Kelly M; Esler MD
    J Hypertens; 1993 Nov; 11(11):1217-27. PubMed ID: 8301103
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cerebral noradrenaline spillover and its relation to muscle sympathetic nervous activity in healthy human subjects.
    Lambert GW; Thompson JM; Turner AG; Cox HS; Wilkinson D; Vaz M; Kalff V; Kelly MJ; Jennings GL; Esler MD
    J Auton Nerv Syst; 1997 May; 64(1):57-64. PubMed ID: 9188086
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased norepinephrine spillover into the jugular veins in essential hypertension.
    Ferrier C; Esler MD; Eisenhofer G; Wallin BG; Horne M; Cox HS; Lambert G; Jennings GL
    Hypertension; 1992 Jan; 19(1):62-9. PubMed ID: 1730441
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monoaminergic neuronal activity in subcortical brain regions in essential hypertension.
    Lambert GW; Ferrier C; Kaye DM; Kalff V; Kelly MJ; Cox HS; Turner AG; Jennings GL; Esler MD
    Blood Press; 1994 Mar; 3(1-2):55-66. PubMed ID: 7515310
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Direct determination of homovanillic acid release from the human brain, an indicator of central dopaminergic activity.
    Lambert GW; Eisenhofer G; Cox HS; Horne M; Kalff V; Kelly M; Jennings GL; Esler MD
    Life Sci; 1991; 49(15):1061-72. PubMed ID: 1895870
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cerebral metabolism and its relationship with sympathetic nervous activity in essential hypertension: evaluation of the Dickinson hypothesis.
    Lambert GW; Vaz M; Rajkumar C; Cox HS; Turner AG; Jennings GL; Esler MD
    J Hypertens; 1996 Aug; 14(8):951-9. PubMed ID: 8884549
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Internal jugular venous spillover of noradrenaline and metabolites and their association with sympathetic nervous activity.
    Lambert GW; Kaye DM; Thompson JM; Turner AG; Cox HS; Vaz M; Jennings GL; Wallin BG; Esler MD
    Acta Physiol Scand; 1998 Jun; 163(2):155-63. PubMed ID: 9648634
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Noradrenaline spillover and microneurography measurements in patients with primary hypertension.
    Jennings GL
    J Hypertens Suppl; 1998 Aug; 16(3):S35-8. PubMed ID: 9747908
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical application of noradrenaline spillover methodology: delineation of regional human sympathetic nervous responses.
    Esler M
    Pharmacol Toxicol; 1993 Nov; 73(5):243-53. PubMed ID: 8115306
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Central nervous system noradrenergic control of sympathetic outflow in normotensive and hypertensive humans.
    Esler MD; Lambert GW; Ferrier C; Kaye DM; Wallin BG; Kalff V; Kelly MJ; Jennings GL
    Clin Exp Hypertens; 1995; 17(1-2):409-23. PubMed ID: 7735286
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Norepinephrine turnover is increased in suprabulbar subcortical brain regions and is related to whole-body sympathetic activity in human heart failure.
    Aggarwal A; Esler MD; Lambert GW; Hastings J; Johnston L; Kaye DM
    Circulation; 2002 Mar; 105(9):1031-3. PubMed ID: 11877349
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Jugular ligation does not increase intracranial pressure but does increase bihemispheric cerebral blood flow and metabolism.
    Chai PJ; Skaryak LA; Ungerleider RM; Greeley WJ; Kern FH; Schulman SR; Hansell DR; Auten RL; Mahaffey SF; Meliones JN
    Crit Care Med; 1995 Nov; 23(11):1864-71. PubMed ID: 7587263
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Central nervous system monoamine neurotransmitter turnover in primary and obesity-related human hypertension.
    Esler M; Lambert G; Vaz M; Thompson J; Kaye D; Kalff V; Kelly M; Turner A; Jennings G
    Clin Exp Hypertens; 1997; 19(5-6):577-90. PubMed ID: 9247740
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanism of elevated plasma noradrenaline in the course of essential hypertension.
    Esler M; Jennings G; Biviano B; Lambert G; Hasking G
    J Cardiovasc Pharmacol; 1986; 8 Suppl 5():S39-43. PubMed ID: 2427882
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Flow dependence of forearm noradrenaline overflow, as assessed during mental stress and sodium nitroprusside infusion.
    Lindqvist M; Melcher A; Hjemdahl P
    J Hypertens; 1999 Jan; 17(1):91-7. PubMed ID: 10100099
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elevated total body noradrenaline spillover in normotensive members of hypertensive families.
    Ferrier C; Cox H; Esler M
    Clin Sci (Lond); 1993 Feb; 84(2):225-30. PubMed ID: 8382587
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Noradrenaline release and sympathetic nervous system activity.
    Esler MD; Hasking GJ; Willett IR; Leonard PW; Jennings GL
    J Hypertens; 1985 Apr; 3(2):117-29. PubMed ID: 2991369
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Region-specific neuropeptide Y overflows at rest and during sympathetic activation in humans.
    Morris MJ; Cox HS; Lambert GW; Kaye DM; Jennings GL; Meredith IT; Esler MD
    Hypertension; 1997 Jan; 29(1 Pt 1):137-43. PubMed ID: 9039093
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.